288 related articles for article (PubMed ID: 27737762)
1. CB
Saravia R; Flores Á; Plaza-Zabala A; Busquets-Garcia A; Pastor A; de la Torre R; Di Marzo V; Marsicano G; Ozaita A; Maldonado R; Berrendero F
Biol Psychiatry; 2017 Apr; 81(7):625-634. PubMed ID: 27737762
[TBL] [Abstract][Full Text] [Related]
2. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
3. Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits.
Subbanna S; Shivakumar M; Psychoyos D; Xie S; Basavarajappa BS
J Neurosci; 2013 Apr; 33(15):6350-66. PubMed ID: 23575834
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food-Restricted Rats: Involvement of CB1 Receptors.
Talani G; Licheri V; Biggio F; Locci V; Mostallino MC; Secci PP; Melis V; Dazzi L; Carta G; Banni S; Biggio G; Sanna E
Neuropsychopharmacology; 2016 Apr; 41(5):1308-18. PubMed ID: 26354043
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
6. The endogenous cannabinoid system modulates nicotine reward and dependence.
Merritt LL; Martin BR; Walters C; Lichtman AH; Damaj MI
J Pharmacol Exp Ther; 2008 Aug; 326(2):483-92. PubMed ID: 18451315
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice.
Dubreucq S; Matias I; Cardinal P; Häring M; Lutz B; Marsicano G; Chaouloff F
Neuropsychopharmacology; 2012 Jul; 37(8):1885-900. PubMed ID: 22434220
[TBL] [Abstract][Full Text] [Related]
8. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
Seillier A; Martinez AA; Giuffrida A
Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
10. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
11. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA
Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
[TBL] [Abstract][Full Text] [Related]
13. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.
Busquets-Garcia A; Puighermanal E; Pastor A; de la Torre R; Maldonado R; Ozaita A
Biol Psychiatry; 2011 Sep; 70(5):479-86. PubMed ID: 21684528
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.
Maccarrone M; Valverde O; Barbaccia ML; Castañé A; Maldonado R; Ledent C; Parmentier M; Finazzi-Agrò A
Eur J Neurosci; 2002 Apr; 15(7):1178-86. PubMed ID: 11982628
[TBL] [Abstract][Full Text] [Related]
16. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.
De Oliveira Alvares L; Genro BP; Diehl F; Quillfeldt JA
Neurobiol Learn Mem; 2008 Jul; 90(1):1-9. PubMed ID: 18342551
[TBL] [Abstract][Full Text] [Related]
17. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.
Navarro-Romero A; Vázquez-Oliver A; Gomis-González M; Garzón-Montesinos C; Falcón-Moya R; Pastor A; Martín-García E; Pizarro N; Busquets-Garcia A; Revest JM; Piazza PV; Bosch F; Dierssen M; de la Torre R; Rodríguez-Moreno A; Maldonado R; Ozaita A
Neurobiol Dis; 2019 May; 125():92-106. PubMed ID: 30685352
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the hippocampal endocannabinoid system in diet-induced obese mice.
Massa F; Mancini G; Schmidt H; Steindel F; Mackie K; Angioni C; Oliet SH; Geisslinger G; Lutz B
J Neurosci; 2010 May; 30(18):6273-81. PubMed ID: 20445053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
